))
We're Well-qualified to Represent the ESG
Manage episode 344826660 series 3281815
Content provided by Brooklyn FI. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Brooklyn FI or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Today, we're hanging with Shane and Kurtis, one of Brooklyn FI's financial planning associates! This week, Texas Pete's hot sauce may be in hot water. A Californian is not loving that the product is manufactured in North Carolina. We’re conflicted by our interest in this story. Intel is set to lay off thousands as PC sales lag, Amazon Prime Day 2.0 fails to impress, and first-time marriages are up for people in their 40s and 50s! The Wall Street Journal says more than 20 percent of federal employees trade stocks in the companies that. they. oversee. Gross! Next up, you'll hear all about YALL, y'all! That's the newest portfolio called the God Bless America ETF. After that, you'll hear about the bubbly, but non-alcoholic Liquid Death, the low-key way to hydrate on a pub crawl, being valued at an impressive $700 million. Finally, you'll hear what's up in European tech as Vodafone seeks to sell off Vantage and a quick rundown of a promising upcoming biotech IPO.
Links
Hot sauce brand in hot water? | LinkedIn
Intel Plans Thousands of Job Cuts in Face of PC Slowdown
Amazon Prime Day 2.0: Boom or bust?
The Wall Street Journal: First-Time Marriages Are on the Rise for People in Their 40s and 50s.
Lancaster, Pa. tops list of best small cities in America: Report
What to know about the application for Biden's student loan relief
White House unveils preview of student loan forgiveness form
Federal Officials Trade Stock in Companies Their Agencies Oversee
Anti ESG ‘God Bless America ETF’ has launched (NYSEARCA:YALL)
Liquid Death Water Startup Valued at $700 Million
Vodafone in advanced talks to finalise Vantage stake sale by Nov. 15 - sources
US IPO Week Ahead: Gene editing biotech plots the first $100+ million IPO of the 4Q
Want to know more about working with BrooklynFI, contact us here
101 episodes
Share
